Philip Morris beats estimates but shares slip on cost pressures

FDA accepts Unicycive resubmission for kidney disease drug

Investing.com · News 9m ago

Agility Robotics expands Pittsburgh facility, adds customers

Investing.com · News 9m ago

Invivyd presents preclinical data on measles antibody candidate

Investing.com · News 9m ago

Opus Genetics receives FDA clearance for RDH12-LCA gene therapy

Investing.com · News 9m ago

Aevex stock drops 5% as US Navy halts $130M drone boat program

Investing.com · Investing_news 10m ago

Will UK Chancellor’s low-key Budget reassure markets before bigger fiscal choices?

Investing.com · Investing_news 14m ago

This is the single-biggest obstacle to a SpaceX-Tesla merger: JPMorgan

Investing.com · Investing_news 16m ago

Roivant’s brepocitinib meets primary endpoint in uveitis trials

Investing.com · News 17m ago

Immunic presents data on vidofludimus calcium at MS conference

Investing.com · News 17m ago

Visa launches AI-powered tools for commercial payments

Investing.com · News 17m ago